English  |  正體中文  |  简体中文  |  Total items :2837387  
Visitors :  39265382    Online Users :  904
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 516651-516700 of 2332462  (46650 Page(s) Totally)
<< < 10329 10330 10331 10332 10333 10334 10335 10336 10337 10338 > >>
View [10|25|50] records per page

Institution Date Title Author
大葉大學 2013-03 Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression Sun, Ding-Ping;CH, Yeh;So, Edmund;Wang, Li-Yun;We, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi
臺北醫學大學 2013 Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi
臺北醫學大學 2013 Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi
臺北醫學大學 2013 Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi
國立成功大學 2013-06 Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression Sun, Ding-Ping; Yeh, Ching-Hua; So, Edmund; Wang, Li-Yun; Wei, Tsui-Shan; Chang, Ming-Shi; Hsing, Chung-Hsi
元培科技大學 2007 Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast like synoviocytes with rheumatoid arthritis via active nuclear factor kappaB and AP-1 dependent pathway Fei-Lan Liu;Jiun-Han Chen; Deh-Ming Chang
元培科技大學 2007 Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-iB and AP-1 dependent pathway F-L Liu;C.-H. Chen;S.-J. Ch;J.-H. Chen; J.-H. Lai; H.-K. Sytwu; D.-M. Chang
臺北醫學大學 2014 Interleukin 10 and clustering of metabolic syndrome components in pediatrics JS, Chang;CH, Bai;ZC, Huang;Owaga, E;KC, Chao;CC, Chang;HY, Chiou
高雄醫學大學 2006 Interleukin 12 A1188C frequency of gastric ulcer patients in Taiwan  鄭宇辰;吳登強;吳宜珍;溫政浩;張學偉 
國立臺灣大學 1990 Interleukin 2 and Lymphokine Activated Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma-a Preliminary Report 謝貴雄; Chang, J. S.; 吳慧琳; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, Hui-Lin; Chu, C. T.
國立臺灣大學 1987 Interleukin 2 and Lymphokine-Activated Killer Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma:A Preliminary Report 謝貴雄; Chang, J. S.; Wu, H. L.; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, H. L.; Chu, C. T.
國立臺灣大學 1991 Interleukin 2 Therapy in Severe Atopic Dermatitis 謝貴雄; Chou, C. C.; Hsieh, Kue-Hsiung; Chou, C. C.
臺大學術典藏 2021-08-19T10:23:39Z Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5 + Stem Cells via Inhibition of Wnt and Notch Signaling Zha J.-M.; Li H.-S.; Lin Q.; WEI-TING KUO; Jiang Z.-H.; Tsai P.-Y.; Ding N.; Wu J.; Xu S.-F.; Wang Y.-T.; Pan J.; Zhou X.-M.; Chen K.; Tao M.; Odenwald M.A.; Tamura A.; Tsukita S.; Turner J.R.; He W.-Q.
臺大學術典藏 2018-09-10T18:05:30Z Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease Chin-Chung Shu and Jann-Yuan Wang and Ming-Fang Wu and Hsin-Chih Lai and Bor-Luen Chiang and Chong-Jen Yu; CHIN-CHUNG SHU; JANN-YUAN WANG
臺大學術典藏 2018 Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease Yu C.-J.; Chiang B.-L.; Lai H.-C.; Wu M.-F.; JANN-YUAN WANG; Shu C.-C.
臺大學術典藏 2020-07-03T04:00:29Z Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease Shu C.-C.;Wang J.-Y.;Wu M.-F.;Hsin-Chih Lai;Chiang B.-L.;Yu C.-J.; Shu C.-C.; Wang J.-Y.; Wu M.-F.; HSIN-CHIH LAI; Chiang B.-L.; Yu C.-J.
臺大學術典藏 2021-06-29T08:39:13Z Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease CHIN-CHUNG SHU; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; Yu C.-J.
臺大學術典藏 2021-07-02T03:41:20Z Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; BOR-LUEN CHIANG; Yu C.-J.
臺大學術典藏 2022-06-27T07:00:01Z Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; CHONG-JEN YU
國家衛生研究院 2025-02-26 Interleukin 26 attenuates osteoblast differentiation in osteoarthritis patients by activating COX2 and NF-κB pathways Lin, YH;Wang, YH;Peng, YJ;Liu, FC;Sytwu, HK;Cheng, CP
國家衛生研究院 2023-04-19 Interleukin 26 induces macrophage IL-9 expression in rheumatoid arthritis Wang, YH;Peng, YJ;Liu, FC;Lin, GJ;Huang, SH;Sytwu, HK;Cheng, CP
國家衛生研究院 2020-04-10 Interleukin 26 skews macrophage polarization towards M1 phenotype by activating cJUN and the NF-kappaB pathway Lin, YH;Wang, YH;Peng, YJ;Liu, FC;Lin, GJ;Huang, SH;Sytwu, HK;Cheng, CP
國立臺灣大學 2012 Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Hsu, Shih-Jer; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 徐士哲; 劉俊人; 陳培哲; 陳俊恒; 林昭維
臺大學術典藏 2018-09-10T09:23:42Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU
臺大學術典藏 2021-05-24T07:20:46Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:27Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-09-04T06:12:00Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
國立臺灣大學 2012 Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳俊恒; 林昭維
臺大學術典藏 2018-09-10T09:23:43Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng
臺大學術典藏 2021-05-24T07:20:46Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:28Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-09-04T06:12:00Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
國立臺灣大學 2010 Interleukin 4 and Stat6 Gene Polymorphisms Are Associated with Systemic Lupus Erythematosus in Chinese Patients 俞欣慧; 劉碧華; 陳為堅; 李志鴻; 王麗潔; 楊曜旭; 江伯倫; YU, HSIN-HUI; LIU, PI-HUA; CHEN, WEI-JANE; LEE, JYH-HONG; WANG, LI-CHIEH; YANG, YAO-HSU; CHIANG, BOR-LUEN
臺大學術典藏 2020-12-08T08:20:26Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Jyh-Hong Lee;Wang L.-C.;Yang Y.-H.;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; JYH-HONG LEE; Wang L.-C.; Yang Y.-H.; Chiang B.-L.
臺大學術典藏 2020-12-21T07:40:27Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Li-Chieh Wang;Yang Y.-H.;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; LI-CHIEH WANG; Yang Y.-H.; Chiang B.-L.
臺大學術典藏 2020-12-17T02:28:42Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yang Y.-H.; Chiang B.-L.; Wang L.-C.; Hsin-Hui Yu;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Wang L.-C.;Yang Y.-H.;Chiang B.-L.; HSIN-HUI YU; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.
臺大學術典藏 2021-01-06T08:23:42Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Wang L.-C.;Yao-Hsu Yang;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; YAO-HSU YANG; Chiang B.-L.
臺大學術典藏 2021-07-02T03:41:57Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; Yang Y.-H.; BOR-LUEN CHIANG
臺大學術典藏 2022-05-05T05:16:09Z Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients Yu H.-H.; Liu P.-H.; Lin Y.-C.; WEI J. CHEN; Lee J.-H.; Wang L.-C.; Yang Y.-H.; Chiang B.-L.
亞洲大學 2005 Interleukin 4 Interleukin 6 and Interleukin 10 Polymorphisms in hildren with Acute and Chronic Immune Thrombocytopenic Purpura Ching-Tien Peng
亞洲大學 2005-03 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura Kang-His Wu;Ching-Tien Peng;Tsai-Chung Li;Lei Wan;Chang-Hai Tsai;Shou-Jen Lan;Ming-Cheng Chang;Fuu-Jen Tsai
亞洲大學 2005 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura 藍守仁
中國醫藥大學 2005-03 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura 巫康熙(Kang-His Wu); 彭慶添(Ching-Tien Peng); 李采娟(Tsai-Chung Li); 萬磊(Lei Wan); 蔡長海(Chang-Hai Tsai); 藍守仁(Shou-Jen Lan); 張明正(Ming-Cheng Chang); 蔡輔仁(Fuu-Jen Tsai)*
中國醫藥大學 2005 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura Wu, KH; Peng, CT; Li, TC; Wan, L; Tsai, CH; Lan, SJ; Chang, MC; Tsai, FJ
中國醫藥大學 2005-11 Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura 巫康熙(Kang-Hsi Wu); 彭慶添(Ching-Tien Peng); 李彩娟(Tsai-Chung LI); 萬磊(Lei Wan); 蔡輔仁(Fuu-Jen Tsai)
國立臺灣大學 2015 Interleukin 6 confers poor prognosis of hepatocellular carcinoma through cancer stemness properties Chang, Te-Sheng; Wu, Yu-Chih; Chi, Ching-Chi; Tung, Shui-Yi; Ling, Thai-Yen; Huang, Yen-Hua; 林泰元

Showing items 516651-516700 of 2332462  (46650 Page(s) Totally)
<< < 10329 10330 10331 10332 10333 10334 10335 10336 10337 10338 > >>
View [10|25|50] records per page